Orphenadrine ("Disipal") in the treatment of Parkinsonism: a two-year study of 150 patients.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009966:Orphenadrine / Q000008:administration & dosage / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D009966:Orphenadrine